Third-Party Payers’ Class Actions For Alzheimer’s Drugs Survive Dismissal
NEW YORK — A New York federal judge on Sept. 13 left unscathed two third-party payer lawsuits alleging that the maker of the Alzheimer’s drug Namenda pulled their original version of...To view the full article, register now.
Already a subscriber? Click here to view full article